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The authors conducted a meta-analysis of published studies to (a) evaluate the premise that a history of 
major depression is associated with failure to quit smoking and (b) identify factors that moderate the 
relationship between history of depression and cessation outcome. Fifteen studies met the selection 
requirements and were coded for various study methodology and treatment characteristics. DSTAT was 
used to calculate individual study effect sizes, determine the mean effect size across studies, and test for 
moderator effects. No differences in either short-term (5 3 months) or long-term abstinence rates (2 6 
months) were observed between smokers positive versus negative for history of depression. Lifetime 
history of major depression does not appear to be an independent risk factor for cessation failure in 
smoking cessation treatment. 
A widespread theory, expressed as the "hardening hypothesis," 
is that the current population of smokers has become increasingly 
refractory to quitting (Hughes, 1996; Irvin & Brandon, 2000). The 
inference is that those who continue to smoke despite strong social 
pressures to quit possess attributes that make it especially difficult 
to stop smoking. One such factor may be a history of major 
depression. The hypothesis that a history of depression constitutes 
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an impediment to smoking cessation emerged in the late 1980s. 
Glassman et al. (1988) first offered that interpretation after ob- 
serving that 57% of smokers who lacked a history of depression 
remained abstinent after 4 weeks of treatment, as compared with 
33% of those who were history pocitive. Subsequent studies by 
Glassman and colleagues showed that the negative effect of de- 
pression on quitting persisted even after the influence of other 
psychiatric comorbidities had been controlled (Glassman et al., 
1990). Moreover, abstinence rates were lower among female 
smokers with recurrent episodes of depression (5%), as compared 
with those with single episodes (35%) (Covey, Glassman, Stetner, 
& Becker, 1993). 
The belief that a history of depression greatly decreases the 
likelihood of quitting smoking has been widely promoted (Anda et 
al., 1990; Glassman, 1993; Glassman, Covey, Stetner, & Rivelli, 
2001; Kinnunen, Henning, & Nordstrom, 1999). The strength of 
this conviction is illustrated by the extent to which attention has 
turned to identifying the mechanisms by which a history of de- 
pression interferes with achieving abstinence. Hypothesized mech- 
anisms include heightened pretreatment dysphoria (Covey, Glass- 
man, & Stetner, 1990), heightened dysphoria following a quit 
attempt (Ginsberg, Hall, Reus, & Mufioz, 1995), or recurrence of 
depression prompted by acute abstinence (Borrelli et al., 1996; 
Glassman et al., 2001). An additional process hypothesized to 
increase risk of relapse is the tendency of depression-vulnerable 
smokers to smoke during dysphoric states (Lerman et al., 1996). 
Although it is generally assumed that a history of depression is 
a barrier to quitting smoking, contradictory evidence also exists 
(Ginsberg et al., 1995; Hall et a]., 1996; Killen et al., 2000; Niaura 
et al., 1999). We conducted a meta-analysis of the published 
literature in an attempt to reconcile the conflicting findings con- 
cerning the influence of a depression history on smoking cessation. 
Our primary aim was to evaluate the premise that history of 
depression is associated with difficulty quitting. We hypothesized 
that smokers positive for a history of depression would show 
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significantly lower abstinence rates than smokers negative for a 
history of depression. A secondary aim was to test whether gender, 
study methodology, or treatment factors moderated the association 
between history of depression and smoking cessation. 
Method 
Literature Search 
We conducted the computerized literature review using Medline (1966- 
2000) and PsycLIT (1971-2000) databases. Two separate searches were 
performed within each database. We first searched using the keywords 
depression and smoking. In our second search, we used the keywords mood 
and smokiizg. In addition, we conducted a manual search of journals most 
likely to have published original articles on depression and smoking 
cessation. We restricted the manual search to articles published in the 
following journals in the year 2000: Journal of Consulting and Clinical 
Psychology, Archives of General Psychiatry, American Journal of Psychi- 
atry, Addiction, Addictive Behaviors, Experimental and Clinical Psycho- 
pharmucologq., Journal of Substance Abuse, and Health Psychology. As a 
final step, we wrote 26 investigators requesting in press studies on depres- 
sion and quitting smoking. Individuals were selected from the membership 
of the Society for Research on Nicotine and Tobacco (2000) on the basis 
of their having conducted prior research on mood and smoking. 
Selection Requirements 
Articles identified through our literature search ( n  = 1,301), including 
the one in-press study received in response to our letter, were evaluated 
further to determine whether they met our inclusion criteria. To be selected, 
studies were required to have (a) a valid assessment of history of depres- 
sion (i.e., no single-item assessments) and (b) a measure of smoking 
cessation outcome. They also were required to be written in English. 
Because our focus was on smokers' ability to achieve abstinence, we 
excluded studies in which outcome was defined as smoking reduction or 
lapse and studies involving retrospective recall of quitting. In addition, case 
studies were excluded because an effect size cannot be derived from 
single-subject designs. 
Fifteen of 18 studies identified were included in our meta-analysis. 
Three met our exclusion criteria. Two studies by Cornelius and colleagues 
(Cornelius et al., 1997; Cornelius, Perkins, Salloum, Thase, & Moss, 1999) 
were excluded because outcome was defined as smoking reduction. A 
study conducted by Glassman et al. (1990) was excluded because outcome 
was based on retrospective recall of smoking cessation. 
Ratings of Study Characteristics 
We developed a coding scheme that would allow us to describe the 
sample of studies in our database as well as to examine in secondary 
analyses study characteristics that might help to account for potential 
moderating effects of depression on smoking cessation. In addition to the 
type of depression assessment (questionnaire, semistructured interview, or 
structured interview), studies were rated on three categories of character- 
istics. The first was methodology, and included nature of sampling, sample 
composition, and study design. Nature of sampling was rated as either 
clinical (treatment sample), epidemiologic (community random sample), or 
sample of convenience (random sample of intact community). Sample 
composition was coded as healthy (no current medical or psychiatric 
illness), medical (unstable medical condition, such as recent myocardial 
infarct), psychiatric (current psychiatric condition. such as alcohol depen- 
dence), or mixed (participants with concurrent medical and major psychi- 
atric illness). Design was rated as either cross-sectional or prospective. 
We coded for two treatment characteristics: modality and intensity. 
Modality was rated as unaided (minimal or no intervention), behavioral 
therapy, pharmacotherapy, or combined behavioral therapy and pharma- 
cotherapy. Intensity was rated as either minimal (5 3 hr total patient- 
therapist contact) or intensive (> 3 hr total contact). The third category was 
smoking status, where we coded for its definition and how and when it was 
assessed. Definition of smoking status was coded as point-prevalent (ab- 
stinence at a single time point), continuous (abstinence between initial 
quitting and a follow-up time point), or prolonged (sustained abstinence 
between two follow-ups). The type of smoking status assessment was 
coded as self-report or self-report with biochemical verification. Smoking 
cessation outcome was rated as either short- (5 3 months) or long-term 
(2 6 months). Classification for the definition of smoking status and 
smoking cessation outcome was based on recommendations made by the 
Society for Research on Nicotine and Tobacco Subcommittee on Absti- 
nence Measures (Hughes et al., 2003). 
Studies were coded independently by two reviewers. When there was 
disagreement, consensus was reached through a third reviewer. Across 
studies and characteristics, there was excellent agreement between raters 
(84.6%). The methodological and treatment characteristics of the studies in 
the meta-analysis are displayed in the Appendix. 
Procedure 
Our analytic procedure consisted of five steps and was based on the 
procedures recommended by Hedges and Olkin (1985). First, we computed 
the effect size, Hedges's g, for each of the identified studies. Because it was 
plausible that the effect of depression on smoking cessation might vary as 
a function of length of outcome, we attempted whenever possible to obtain 
separate effect sizes for both short- and long-term cessation. Effect sizes 
were calculated using the meta-analytic program DSTAT and the following 
equation (Johnson, 1989). 
P, represents the proportion abstinent for the history positives, PC repre- 
sents the proportion abstinent for history negatives, and S,,,,,, represents 
the pooled standard deviation between the two groups. Data for this 
computation were available in 12 of 15 studies. For 2 of the 3 remaining 
studies (Keuthen et al., 2000; Killen et al., 2000), we obtained group- 
specific abstinence rates from the authors. For the 3rd study (Prochazka et 
al., 1998), we assigned an effect size estimate of 0.00 and a one-tailed p of 
.50 following the recommendation by Rosenthal (1995). For all studies, we 
extracted data on point-prevalence abstinence that had been derived on 
an intent-to-treat basis. Effect size estimates were weighted by study 
sample sizes (weighted effect size = d,). A negative sign indicated lower 
abstinence rates for history positive smokers. Next, to determine the 
overall strength of the association between depression history and cessation 
outcome, we calculated the mean effect size for short- and long-term 
abstinence. 
We examined the consistency of individual study effect sizes in the third 
step. To maintain the assumption of independent sets of effect sizes, we 
included only one effect size estimate from each study for each category of 
outcome. When a study offered more than one outcome that met our 
criteria for either short- (5 3 months) or long-term cessation (2 6 months), 
we selected the furthest assessment time point that fit within our definition. 
For example, if a study assessed abstinence at both I-week and I-month 
postquit, we selected the I-month data and coded them as "short-term" 
outcome. If an aggregated effect size was found to be heterogeneous, 
outlier effects were deleted individually and we recalculated the homoge- 
neity statistic (Q,). Outliers were deleted one at a time until we observed 
a homogeneous effect (i.e., variability around the mean is no greater than 
that expected from sample error alone). 
In the fourth step, we calculated effect sizes separately for females and 
males to examine whether gender influenced either the magnitude or 
direction of the aggregated effect sizes for either short- or long-term 
cessation. Of the 15 studies, 3 reported gender-specific abstinence rates 
(Covey et al., 1993; Covey, Glassman, & Stetner, 1999; Hall et al., 1998). 
For the 12 studies in which these data were unavailable, we sent a letter to 
the authors requesting them. We obtained gender-specific abstinence data 
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for all but 3 studies (Ginsberg et al., 1995: Glassman et al., 1988; 
Prochazka et al., 1998). In the final step, we tested whether any of the 
methodology or treatment factors were significant moderators of the 
depression-outcome relationship. A fixed-effects model was used for all 
tests of between-class effects (Q,). 
Results 
A summary of the coded study characteristics is presented in 
Table 1. Studies were predominately clinical trials (93%; n = 14) 
involving "healthy" smokers (87%; n = 13). Except for the study 
by Muiioz, Marin, Posner, and Perez-Stable (1997), all of the 
treatment studies excluded smokers with current medical or psy- 
chiatric illness. The majority of studies involved intensive inter- 
ventions (67%; n = 10) combining cognitive-behavioral therapy 
and pharmacotherapy (73%; n = 11). Biochemically verified ab- 
stinence (e.g., expired carbon monoxide) was obtained in most 
studies (80%; n = 12). Most depression assessments were struc- 
tured interviews (73%; n = 1 I). Across the 15 studies, the mean 
percentage of smokers with a history of depression was 34% 
(SD = 15.0; range = 12% to 64%). Overall, 2,984 participants 
were involved. Twenty-nine percent of these (n = 875) were 
classified as having a history of depression. Data on treatment drop 
out by depression history were available in 5 of 14 treatment 
studies (Glassman et al., 1993; Ginsberg et al., 1995; Hall et al., 
1998; Keuthen et a]., 2000; Niaura et al., 1999). None showed a 
differential dropout. 
Table 1 
Characteristics of  Coded Studies 
Variable No. of studies % 
Sampling 
Clinical 
Epidemiological 
Design 
Prospective 
Cross-sectional 
Sample 
Healthy 
Medical 
Psychiatric 
Mixed 
Treatment modality 
Unaided 
Behavioral treatment 
Combined treatment 
Treatment intensitya 
Minimal 
Intensive 
Abstinence definition 
Point prevalence 
Continuous abstinence 
Prolonged abstinence 
Abstinence assessment 
Self-report 
Biochemical validation 
Type of depression assessment 
Single item 
Questionnaire 
Structured interview 
a Numbers do not sum to 15 because Breslau, Kilbey, and Andreski (1993) 
was not a treatment study. 
Effect of History of Depression on Smoking Cessation 
Contrary to expectations, there was no effect of history of 
depression on short-term abstinence, d+ = -.05,95% confidence 
interval (CI) = -.14, .04, counternull d+ = -.lo, p = .18. The 
test of homogeneity revealed a homogeneous effect, 
Q,,,,, = 17.37, p = .18, indicating consistency among the effect 
size estimates of short-term abstinence (see Figure 1). Only 2 of 13 
studies (Covey et al., 1993; Glassman et al., 1988) supported the 
hypothesis that history of depression negatively influences cessa- 
tion outcome. We observed a similar pattern for long-term absti- 
nence, where only 1 of 12 studies (Glassman et al., 1993) yielded 
a significant effect size estimate (see Figure 2). Again, when effect 
sizes were aggregated, the effect of depressive history was non- 
significant, d+ = -.06, 95% CI = -.15, .04, counternull d+ = 
-.12, p = .18, and homogeneous, Q,(,,, = 13.79, p = .31. 
Results were unchanged when the one nontreatment study 
(Breslau, Peterson, Schultz, Chilcoat, & Andreski, 1998) was 
excluded from the analysis, d+ = -.05, 95% CI = - .15, .04, p = 
.21. The test of between-class effects revealed nonsignificant dif- 
ferences between short- and long-term outcome, Q,(,, < 0.00, p = 
.99. Sample sizes and intent-to-treat quit rates for short- and 
long-term outcome are presented in Table 2. 
Analyses of Moderator Effects 
Given that women are almost twice as llkely as men to experi- 
ence depression (Weissman et al., 1996), we considered it plausi- 
ble that gender might influence the magnitude and/or direction of 
the association between history of depression and smoking cessa- 
tion. Gender-specific effect sizes for short- and long-term absti- 
nence were computed using Hedges and Olkin's formula for 
proportionlfrequency data (see equation). 
For men, when effect sizes were aggregated for short-term 
outcome, history of depression did not influence abstinence rates, 
d+ = -.01, 95% CI = -.15, .13, p = 34 .  The test of homoge- 
neity revealed a homogeneous overall effect, Q,(,,, = 11.23, p = 
.34. We observed the same for long-term abstinence. The overall 
effect size was nonsignificant, d+ = -.09, 95% CI = -.25, .06, 
p = .14, and homogeneous, Qwo, = 3.87, p = 37 .  
When effect sizes of short-term outcome were aggregated for 
women, results revealed a nonsignificant effect of history of de- 
pression on abstinence, d+ = .05, 95% CI = -.07, .17, p = .37, 
that was heterogeneous, Q,(,,, = 18.64, p = .04. Deletion of one 
outlier (Covey et al., 1999) yielded a homogeneous overall effect, 
d+ = .07, 95% CI = - .05, .20, p = .19, Q , = 14.73, p = . lo. 
The effect for women for long-term cessation also was nonsignif- 
icant, d+ = -.05, 95% CI = -.la, .07, p = .37, and heteroge- 
neous, Q,,,, = 24.83, p = .002. Deletion of two outliers (Covey 
et al., 1999; Glassman et a]., 1993) yielded a homogeneous effect, 
Q ,, = 24.83, p = .05, that remained nonsignificant, d+ = .09, 
95% CI = -.06, .24, p = .19. Similar to the procedure followed 
in the overall analysis, we conducted tests of between-class effects 
to examine whether gender moderated the association between 
history of depression and smoking cessation. Results of the anal- 
ysis of short-term abstinence revealed no difference between men 
and women in effect size estimates, Q,(,, = 0.84, p = .36. For 
long-term abstinence, the difference approached significance, 
Q ,,,, = 2.79, p = .09. 
We also considered it plausible that the association between 
history of depression and smoking cessation may be moderated by 
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Effect Size (Weighted by Sample Size) 
Glassman et al. (1 988) 
Covey et al. (1 993) - 
Glassman et al. (1 993) - 
Hall et al. (1994) - 
Ginsberg et al. (1 995) - 
Hall et al. (1996) - 
Munoz et al. (1 997) - 
Hall et al. (1 998) - 
Hayford et al. (1999) - 
Niaura et al. (1999) - 
Covey et al. (1 999) - 
Killen et al. (2000) - 
Keuthen et al. (2000) - 
Figure I .  Effect size estimates for short-term abstinence (5 3 months) weighted by sample sizes. 
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Figure 2.  Effect size estimates for long-term abstinence ( Z  6 months) weighted by sample sizes. 
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Table 2 
Sample Sizes and Intent-to-Treat Quit Rates Across Studies for Smokers Positive ( H x + )  Versus 
Negative ( H x - )  for History of Depression at Short- and Long-Term Outcome 
Short term Long term 
N % quit % quit 
Study (Hx+/Hx-) (Hx+/Hx-) Time (Hx+/Hx-) Time 
Glassman et al. (1988) 
Covey et al. (1993) 
Glassman et al. (1993) 
Hall et al. (1994) 
Ginsberg et al. (1995) 
Hall et al. (1996) 
Muiioz et al. (1997) 
Breslau et al. (1998) 
Hall et al. (1998) 
Prochazka et al. (1998) 
Covey et al. (1999) 
Hayford et al. (1999) ' 
Niaura et al. (1999)" 
Killen et al. (2000) 
Keuthen et al. (2000) 
4 week 
10 week 
10 week 
12 week 
2 week 
12 week 
12 week 
- 
12 week 
4 week 
6 week 
4 week 
10 week 
10 week 
26 week 
52 week 
52 week 
52 week 
26 week 
5 year 
64 week 
26 week 
26 week 
52 week 
- 
26 week 
26 week 
Note. Abstinence rates are presented using the following fonnat: (percentage abstinent for depression history 
positivelpercentage abstinent for depression history negative). Dashes indicate the data are not available. 
" Sample sizes and quit rates are based on the entire sample of participants who completed the trial ( N  = 183), 
as opposed to only the subsample (n = 133) studied in Niaura et al. (1999). 
methodological or treatment characteristics. Cell sizes for most of 
the proposed moderators were small and unequal (see Table 1). We 
analyzed the variables in which there were at least two cells with 
greater than two cases. Results showed that the effect of history of 
depression on short- or long-term abstinence did not differ as a 
function of sample composition, time interval since last depressive 
episode, treatment modality or intensity, nature of smoking status, 
or depression assessment. 
Discussion 
A strength of meta-analyses is that they have the potential to 
provide an objective appraisal of the empirical evidence (Hedges 
& Olkin, 1985). We found that a lifetime history of major depres- 
sion did not independently increase the risk of either short- or 
long-term smoking cessation failure. Moreover, we found that the 
influence of depression on abstinence was no greater for female 
smokers than male smokers. Although limited by the homogeneity 
of study characteristics, as well as the small and unequal sample 
sizes, we also observed that none of the methodology or treatment 
factors moderated the depression-abstinence relationship. 
Our findings indicate that knowing whether a smoker has a 
history of depression yields little or no predictive information 
regarding his or her ability to stop smoking within the context of 
intensive smoking cessation treatment. It remains possible that 
recurrent depression, in contrast to single-episode depression, 
might have negative implications for smoking cessation. The ra- 
tionale is that a multiple episode history may reflect a substantial 
underlying vulnerability to disorder (Zubin & Spring, 1977). 
Single-episode depression, in contrast, may occur serendipitously 
even among individuals of low psychopathologic vulnerability, if 
they encounter sufficiently major loss or other significant life 
stressors. Three studies have distinguished between smokers with 
single versus recurrent depression. Glassman et al. (1993) found 
that smokers with recurrent depression were at a greater risk for 
relapse than those with a single-episode history. In a study by 
Covey et al. (1999), women with recurrent depression, but not 
men, were at increased risk for relapse. The hypothesis that a 
recurrent history of depression, as opposed to single-episode de- 
pression, increases risk for poor outcome also was supported in a 
recent study by Brown et al. (2001) that tested the efficacy of 
mood management-smoking cessation treatment versus standard 
treatment in 179 smokers. All participants had a lifetime history of 
depression. Among those who received standard treatment, history 
of recurrent depression, but not single-episode depression, pre- 
dicted relapse. Overall, smokers with recurrent depression who 
received mood management were more likely to be abstinent than 
those who received standard treatment. 
Risk for cessation failure among depression prone smokers is 
likely conveyed through a combination of enduring trait vulnera- 
bility, reflected by a history of recurrent depression, and a vulner- 
able state, reflected by elevated depressive symptomatology prior 
to treatment (Borrelli et al., 1999; Niaura & Abrams, 2001). Future 
research should determine the attributes that characterize the de- 
pression vulnerable smokers who are at greatest risk for failure. On 
the basis of our findings, simply knowing that a smoker has a 
history of depression is uninformative regarding his or her ability 
to stop smoking. Potentially more informative predictors that warrant 
further investigation include recurrence of depression, episode dura- 
tion or recency, or even specific symptoms (e.g., depressed mood) or 
clusters of symptoms (Niaura & Abrarns, 2001). Because of possible 
differences in rates and symptoms of depression across adulthood 
(Karel, 1997), future studies should also consider the influence of age. 
Also unanswered is whether current major depression is a sig- 
nificant barrier to smoking cessation. One might expect depressed 
patients to be at high risk for cessation failure, given that even low 
levels of pretreatment depressive symptomatology predict time to 
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relapse (Niaura et al., 2001). However, treatment-related quit rates 
among smokers with current depression have rarely been studied. 
Depressed smokers are almost always excluded from smoking 
cessation treatment studies, especially those involving antidepres- 
sant pharmacotherapy. There have been only two published studies 
involving smokers with current major depression (Mufioz et al., 
1997; Thorsteinsson et al., 2002). Results of both indicate that 
depressed patients may be capable of achieving short-term absti- 
nence at rates comparable to those of nondepressed smokers, 
although a question can be raised about the representativeness of 
depressed people with sufficient motivation and energy to seek 
cessation treatment. 
Several limitations should be considered. First, given that the 
current meta-analysis involved fixed-effects modeling of a homo- 
geneous sample, our findings generalize only to the types of 
studies represented: "healthy" smokers involved in clinical trials of 
intensive, combined pharmacological plus psychological interven- 
tions. Whether they generalize to smokers with concurrent medical 
and/or psychiatric illness, continuous or prolonged abstinence, 
cross-sectional studies of the association between depression and 
smoking status, or prospective, population-based smoking cessa- 
tion studies remains to be determined. Second, despite the large 
sample of studies identified through the literature search, only a 
small number reported an assessment of lifetime history of depres- 
sion and evaluated its association with smoking cessation. Conse- 
quently, the power of our statistical tests was low (.24 for the 
analysis of short-term outcome and .23 for that of long-term 
outcome). The extent to which this should influence interpretations 
of our findings is uncertain. Using the procedures developed by 
Hedges and Pigott (2001) for computing the power of statistical 
tests in meta-analyses, we estimated that an additional 61 studies, 
each involving 198 participants (12,078 overall), would be re- 
quired for power = .SO. Even if sufficiently powered and statisti- 
cally significant, it is unlikely that effect sizes of the magnitude we 
observed (short-term d ~ ,  = - .05, long-term d+ = - .06) would be 
meaningful clinically. Third, only 4 of 15 studies (Glassman et al., 
1993; Hall, MuAoz, & Reus, 1994, Hall et al., 1996, 1998) in- 
cluded in our meta-analysis were designed to test whether history 
of depression influences cessation outcome. Only 1 (Killen et al., 
2000) was designed to detect gender differences in outcome. 
Studies based on post hoc analyses of outcome data, as opposed to 
those designed to test the moderating influence of third variables 
using stratified randomization, have the potential to be misleading 
(Killen, Fortmann, Varady, & Kraemer, 2002). Future studies 
examining the moderating influences of depression and gender on 
cessation outcome should stratify randomization on these factors. 
Refining understanding of whether and how depression- 
vulnerable smokers may be at heightened risk for smoking cessa- 
tion failure is especially crucial given the extent to which both 
clinicians and researchers have accepted the early, but most often 
unreplicated, finding that a history of depression is a barrier to 
quitting smoking. A negative consequence of this assumption from 
a research perspective has been the premature focus on developing 
intensive, specialized treatments for all smokers with a positive 
history of depression. From a clinical perspective, it is possible 
that many history-positive smokers have been either encouraged to 
pursue unnecessarily intensive treatments or indirectly discour- 
aged from quitting altogether, even though they were as likely as 
history-negative smokers to achieve abstinence. 
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Appendix 
Summary of Methodology and Treatment Characteristics for Studies Included in the Meta-Analysis 
Entry Depression Abstinence Treatment Treatment Depression 
Study Sampling Sample smoking exclusion assessment modality intensity assessment 
Glassman et al. (1988) 
Covey et al. (1993) 
Glassman et al. (1993) 
Hall et al. (1994) 
Ginsberg et al. (1995) 
Hall et al. (1996) 
Muiioz et al. (1997) 
Breslau et al. (1998) 
Hall et al. (1998) 
Prochazka et al. (1998) 
Covey et al. (1999) 
Hayford et al. (1999) 
Niaura et al. (1999) 
Keuthen et al. (2000) 
Killen et al. (2000) 
clinical 
clinical 
clinical 
clinical 
clinical 
clinical 
clinical 
epi 
clinical 
clinical 
clinical 
clinical 
clinical 
clinical 
clinical 
healthy 
healthy 
healthy 
healthy 
healthy 
healthy 
mixed 
mixed 
healthy 
healthy 
healthy 
healthy 
healthy 
healthy 
healthy 
2 2 0  cigs/daya 
2 2 0  cigslday 
2 2 0  cigslday 
> 10 cigslday 
2 1 0  cigslday 
2 10 cigslday 
2 3  cigslday 
none 
> 10 cigslday 
2 10 cigslday 
2 2 0  cigslday 
2 15 cigslday 
daily 
dailyb 
2 10 cigslday 
current 
<6 months 
<6 months 
<6 months 
<6 months 
<3 months 
none 
none 
1 3  months 
current 
current 
current 
current 
current 
current 
self-report 
biochemical 
biochemical 
biochemical 
biochemical 
biochemical 
biochemical 
self-report 
biochemical 
biochemical 
biochemical 
self-report 
biochemical 
biochemical 
biochemical 
combined 
combined 
combined 
combined 
behavioral 
combined 
behavioral 
unaided 
combined 
combined 
combined 
combined 
behavioral 
combined 
combined 
intensive 
intensive 
intensive 
intensive 
intensive 
intensive 
minimal 
no treatmel 
intensive 
intensive 
intensive 
minimal 
minimal 
intensive 
minimal 
stmct interview (SADS) 
struct interview (SCID) 
stmct interview (SCID) 
struct interview (DIS) 
struct interview (DIS) 
self-report (comp DIS) 
struct interview (DIS) 
11 struct interview (DIS) 
self-report (comp DIS) 
self-report (comp DIS) 
stmct interview (SADS) 
struct interview (SCID) 
two-item self-report 
struct interview (SCID) 
stmct interview (SCID) 
Note. Entry smoking = required or observed smoking rate; biochemical = biochemical confirmation of self-reported smoking status; depression 
exclusion = exclusion criteria for time interval since last depressive episode. cigs = cigarettes; stmct = structured; SADS = Schedule for Affective 
Disorders and Schizophrenia; DIS = Diagnostic Interview Scale; SCID = Structured Clinical Interview for the DSM-IV; comp DIS = computerized 
version of the DIS; epi = epidemiological. 
a Also required 50% reduction in cigslday by quit date. Also required expired carbon monoxide levels 2 8 parts per million. 
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